Monitoring C-Reactive Protein in Biologic Naive Patients With Ulcerative Colitis Undergoing Infliximab Remission Induction Therapy

被引：0
|
作者：
Suzuki, Yasuo
Iwasa, Ryota
Yamada, Akihiro
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1122
引用
收藏
页码：S381 / S381
页数：1
相关论文
共 50 条
  • [41] SERUM C-REACTIVE PROTEIN AS AN INDICATOR OF ACTIVE ULCERATIVE-COLITIS EXTENT
    PRANTERA, C
    LORENZETTI, R
    DAVOLI, M
    PALLONE, F
    MARCHEGGIANO, A
    GASTROENTEROLOGY, 1987, 92 (05) : 1579 - 1579
  • [42] C-Reactive Protein Correlates with Tumor Necrosis Factor-a in Ulcerative Colitis
    McDonagh, P.
    O'Connell, F.
    O'Connell, J.
    Argue, R.
    Corcoran, R.
    Kevans, D.
    O'Sullivan, J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S184 - S186
  • [43] C-reactive protein-to-albumin ratio and neutrophil-to-albumin ratio for predicting response and prognosis to infliximab in ulcerative colitis
    Zhang, Yanyan
    Xu, Feng
    Li, Ya
    Chen, Bing
    FRONTIERS IN MEDICINE, 2024, 11
  • [44] Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis
    Riviere, P.
    Le Chevillier, A.
    Rullier, A.
    Marty, M.
    Schurr, E.
    Lapuyade, B.
    Celerier, B.
    Fernandez, B.
    Bessissow, T.
    Treton, X.
    Uzzan, M.
    Poullenot, F.
    Berger, A.
    Zerbib, F.
    Laharie, D.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (09) : 1194 - 1200
  • [45] Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
    Farkas, Klaudia
    Lakatos, Peter Laszlo
    Nagy, Ferenc
    Szepes, Zoltan
    Miheller, Pal
    Papp, Maria
    Palatka, Karoly
    Balint, Anita
    Bor, Renata
    Wittmann, Tibor
    Molnar, Tamas
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (12) : 1394 - 1398
  • [46] Endoscopic severity and C-reactive protein level predict failure of medical rescue therapy in patients with acute severe ulcerative colitis
    Subhaharan, D.
    Ramaswamy, P. Kakkadasam
    Moattar, H.
    Shukla, D.
    Ishaq, N.
    Bhullar, M.
    Dorrington, A.
    Sawyer, E.
    James, R.
    McLean, R.
    Oriss, R.
    Lyons, T.
    Edwards, J.
    Mohsen, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 154 - 155
  • [47] Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
    Jurgens, Matthias
    John, Jestinah M. Mahachie
    Cleynen, Isabelle
    Schnitzler, Fabian
    Fidder, Herma
    Van Moerkercke, Wouter
    Ballet, Vera
    Noman, Maja
    Hoffman, Ilse
    Van Assche, Gert
    Rutgeerts, Paul J.
    Van Steen, Kristel
    Vermeire, Severine
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (05) : 421 - U1420
  • [48] Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naive Patients with Ulcerative Colitis
    Dalal, Rahul S.
    McClure, Emma L.
    Marcus, Jenna
    Allegretti, Jessica R.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (01) : 223 - 232
  • [49] C-reactive protein level at time of discharge predicts steroid-free remission and re-presentation to hospital in immunosuppressant-naive patients with ulcerative colitis treated with 5-aminosalicylate therapy after admission with acute severe ulcerative colitis responsive to corticosteroids
    Tambakis, G.
    Croft, A.
    Walker, G.
    Radford-Smith, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 132 - 133
  • [50] Comparison of Long-term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naive Patients with Ulcerative Colitis
    Lee, Yong Il
    Park, Yehyun
    Park, Soo Jung
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    GUT AND LIVER, 2021, 15 (02) : 232 - 242
12345